Buy INFLECTRA 100 mg/10mL infliximab-dyyb

Inflectra 100 mg/10mL is a lyophilized powder for solution, used for intravenous administration. This medication, containing infliximab-dyyb, is designed to help manage certain inflammatory conditions. Learn more about its uses and effects.

Strength

100 mg/10mL

Pack Size

1 VIAL, SINGLE-USE in 1 CARTON (0069-0809-01) / 10 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Inflectra 100 mg/10mL is primarily used for the treatment of inflammatory conditions. It is often prescribed for conditions such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Patients may wonder, 'What is Inflectra used for?' This medication is designed to help reduce inflammation and improve symptoms associated with these conditions.

Side Effects

Common effects of Inflectra 100 mg/10mL may include infusion reactions, infections, and increased risk of certain cancers. Patients should be monitored for any adverse reactions during and after administration. It is important to discuss any concerns with a healthcare provider.

Precautions & Warnings

Inflectra 100 mg/10mL should be handled with care and administered by a healthcare professional. It is crucial to follow proper storage and preparation guidelines to ensure safety. Patients with a history of severe allergies or infections should inform their healthcare provider before use.

Avoid Interactions

Inflectra 100 mg/10mL may interact with other medications, including those that suppress the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.

References

Frequently Asked Questions

Inflectra is used to manage inflammatory conditions such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis.

Inflectra is administered intravenously as a solution prepared from a lyophilized powder.

Common side effects may include infusion reactions, infections, and an increased risk of certain cancers.

Inflectra may interact with other medications, especially those that suppress the immune system. Consult a healthcare provider for guidance.

Inflectra should be stored according to the manufacturer's guidelines to maintain its efficacy and safety.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.